A detailed history of Allianz Asset Management Gmb H transactions in Moderna, Inc. stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 95,081 shares of MRNA stock, worth $3.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
95,081
Previous 6,100 1458.7%
Holding current value
$3.5 Million
Previous $724,000 777.62%
% of portfolio
0.01%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$63.64 - $125.14 $91,450 - $179,826
1,437 Added 1.53%
95,081 $6.35 Million
Q2 2024

Aug 13, 2024

BUY
$101.21 - $166.61 $835,083 - $1.37 Million
8,251 Added 9.66%
93,644 $11.1 Million
Q1 2024

May 13, 2024

SELL
$85.37 - $115.44 $2.11 Million - $2.85 Million
-24,664 Reduced 22.41%
85,393 $9.1 Million
Q4 2023

Feb 12, 2024

SELL
$69.51 - $104.43 $11.6 Million - $17.5 Million
-167,470 Reduced 60.34%
110,057 $10.9 Million
Q3 2023

Nov 13, 2023

SELL
$96.41 - $126.61 $4.44 Million - $5.83 Million
-46,048 Reduced 14.23%
277,527 $28.7 Million
Q2 2023

Aug 11, 2023

SELL
$118.5 - $160.53 $7.36 Million - $9.97 Million
-62,132 Reduced 16.11%
323,575 $39.3 Million
Q1 2023

May 11, 2023

BUY
$135.66 - $197.02 $11.4 Million - $16.6 Million
84,280 Added 27.96%
385,707 $59.2 Million
Q4 2022

Feb 13, 2023

BUY
$118.38 - $210.04 $3.01 Million - $5.34 Million
25,400 Added 9.2%
301,427 $54.1 Million
Q3 2022

Nov 08, 2022

SELL
$118.07 - $194.18 $65.8 Million - $108 Million
-557,309 Reduced 66.88%
276,027 $32.6 Million
Q2 2022

Aug 12, 2022

BUY
$117.13 - $176.59 $2.22 Million - $3.34 Million
18,931 Added 2.32%
833,336 $119 Million
Q1 2022

May 13, 2022

SELL
$126.46 - $235.05 $90.5 Million - $168 Million
-715,367 Reduced 46.76%
814,405 $140 Million
Q4 2021

Feb 11, 2022

BUY
$225.82 - $368.51 $118 Million - $192 Million
521,834 Added 51.77%
1,529,772 $388 Million
Q3 2021

Nov 10, 2021

SELL
$221.9 - $484.47 $214 Million - $468 Million
-966,235 Reduced 48.94%
1,007,938 $388 Million
Q2 2021

Aug 16, 2021

SELL
$129.91 - $234.98 $82.9 Million - $150 Million
-638,178 Reduced 24.43%
1,974,173 $464 Million
Q1 2021

May 13, 2021

BUY
$109.18 - $185.98 $256 Million - $437 Million
2,347,122 Added 884.94%
2,612,351 $342 Million
Q4 2020

Feb 16, 2021

SELL
$65.74 - $169.86 $5.81 Million - $15 Million
-88,362 Reduced 24.99%
265,229 $27.7 Million
Q3 2020

Nov 13, 2020

BUY
$54.34 - $94.85 $909,868 - $1.59 Million
16,744 Added 4.97%
353,591 $25 Million
Q2 2020

Aug 14, 2020

BUY
$29.67 - $80.0 $505,072 - $1.36 Million
17,023 Added 5.32%
336,847 $21.6 Million
Q1 2020

May 14, 2020

BUY
$17.78 - $31.58 $5.69 Million - $10.1 Million
319,824 New
319,824 $9.58 Million
Q4 2019

Feb 13, 2020

SELL
$13.93 - $21.28 $139,717 - $213,438
-10,030 Closed
0 $0
Q3 2019

Nov 13, 2019

BUY
$12.26 - $18.07 $122,967 - $181,242
10,030 New
10,030 $160,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Allianz Asset Management Gmb H Portfolio

Follow Allianz Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.